OQROGet OQRO Pro
Insider trade

Entrada Therapeutics (TRDA)10% owner sold ~$205K

MPM BIOVENTURES 2018, 10% owner at Entrada Therapeutics, sold ~$205K of Entrada Therapeutics shares.

~$205K
Approx. value · 29K sh @ $7.06
4.2M
Holds after · shares reported
Traded
Sep 1, 2026
Filed
Sep 3, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 30, 2026Insider · 2 peopleInsiders: 2 sales (~$1.6M)
  2. Jul 31, 2026Insider · 2 peopleInsiders: 2 sales (~$24K)
  3. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
  4. Aug 6, 2026Insider · 2 peopleInsiders: 2 sales (~$147K)
  5. Aug 7, 2026Insider · 2 peopleInsiders: 2 sales (~$717K)
  6. Aug 10, 2026InsiderDirector sold ~$647K of TRDA shares in the open market
  7. Aug 24, 2026Insider · 2 peopleInsiders: 2 sales (~$317K)
  8. Aug 25, 2026Insider · 2 peopleInsiders: 2 sales (~$400K)
  9. Aug 26, 2026Insider · 2 peopleInsiders: 2 sales (~$206K)
  10. Aug 27, 2026Insider · 2 peopleInsiders: 2 sales (~$560K)
  11. Aug 28, 2026Insider · 2 peopleInsiders: 2 sales (~$52K)
  12. Aug 31, 2026Insider · 2 peopleInsiders: 2 sales (~$619K)
  13. Sep 1, 2026 · this disclosureInsider10% owner sold ~$205K of TRDA shares in the open market

What came next

  1. Sep 1, 2026Insider10% owner sold ~$205K of TRDA shares in the open market
  2. Sep 2, 2026Insider · 2 peopleInsiders: 2 sales (~$361K)
  3. Sep 3, 2026Insider · 2 peopleInsiders: 2 sales (~$463K)
  4. Sep 4, 2026Insider · 2 peopleInsiders: 2 sales (~$547K)
  5. Sep 8, 2026Insider · 2 peopleInsiders: 2 sales (~$2.9M)
  6. Sep 9, 2026Insider · 2 peopleInsiders: 2 sales (~$411K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Entrada Therapeutics

For Entrada Therapeutics, OQRO holds 33 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TRDA page.

Other recent filings by MPM BIOVENTURES 2018, L.P., 10% owner

The full history of MPM BIOVENTURES 2018, L.P., 10% owner is on the profile page.

How this filing works

Other disclosures at Entrada Therapeutics

Everything OQRO holds on this company is on its TRDA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data